Does QUAVONLIMAB Cause Malignant neoplasm progression? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with QUAVONLIMAB. This represents 1.9% of all adverse event reports for QUAVONLIMAB.
7
Reports of Malignant neoplasm progression with QUAVONLIMAB
1.9%
of all QUAVONLIMAB reports
6
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From QUAVONLIMAB?
Of the 7 reports, 6 (85.7%) resulted in death, 6 (85.7%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for QUAVONLIMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does QUAVONLIMAB Cause?
Diarrhoea (26)
Anaemia (24)
Colitis (22)
Hyponatraemia (18)
Acute kidney injury (14)
Pneumonia (11)
Adrenal insufficiency (10)
Alanine aminotransferase increased (9)
Dehydration (9)
Hypertension (9)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which QUAVONLIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
QUAVONLIMAB vs QUINACRINE
QUAVONLIMAB vs RADIATION THERAPY
QUAVONLIMAB vs RADIUM RA-223 DICHLORIDE
QUAVONLIMAB vs RALTITREXED
QUAVONLIMAB vs RAMUCIRUMAB